Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSG | P08311 | 2/20 | 0.35 |
| ▸ | CMA1 | P23946 | 2/20 | 0.35 |
| ▸ | F10 | P00742 | 1/20 | 0.35 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.34 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.34 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.34 |
| ▸ | OPRD1 | P41143 | 3/20 | 0.33 |
| ▸ | CACNA1G | O43497 | 1/20 | 0.33 |
| ▸ | PTGER2 | P43116 | 1/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL8571507 | 0.99 | CTSG (0.34) | CTSGCMA1F10MTNR1ATBXA2R | |
| SCHEMBL8415372 | 0.95 | OPRD1 (0.39) | CTSGCMA1OPRD1 | |
| Hydrochloric Acid SCHEMBL8576436 | 0.94 | OPRD1 (0.39) | CTSGCMA1OPRD1 | |
| SCHEMBL8416012 | 0.91 | PTGER3 (0.35) | F10MTNR1AOPRD1PTGER2 | |
| SCHEMBL8413437 | 0.85 | OPRD1 (0.40) | OPRD1PTGER2 | |
| Hydrochloric Acid SCHEMBL8573565 | 0.82 | CTSG (0.39) | CTSGCMA1 | |
| SCHEMBL8575092 | 0.80 | CTSG (0.43) | CTSGCMA1 | |
| Hydrochloric Acid SCHEMBL8575626 | 0.79 | CTSG (0.42) | CTSGCMA1 | |
| SCHEMBL8577383 | 0.79 | MAPT (0.36) | CTSGCMA1CACNA1G | |
| SCHEMBL8575396 | 0.78 | CTSG (0.36) | CTSGCMA1CACNA1G |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5880284-A | HAVING ANTITHROMBOTIC, ANTIAGGREGATORY AND TUMOR- OR METASTASES-INHIBITING EFFECTS | DR. KARL THOMAE GMBH (DE) | 1999-03-09 | — | — | US | disclosed |
| US-5681841-A | PREVENTION CELL AGGREGATION | KARL THOMAE GMBH (DE) | 1997-10-28 | — | — | US | disclosed |